ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 032,54
-0,33%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Anacor Pharmaceuticals, Inc. (ANAC)

  7. Anacor Pharmaceuticals, Inc. (ANAC) Actualités

ANAC

Anacor Pharmaceuticals, Inc. (ANAC)

Anacor Pharmaceuticals, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ANAC
DateHeureSourceTitreSymboleSociété
11/07/201622h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
05/07/201623h02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
30/06/201612h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201621h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201615h34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201615h27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201615h24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201615h23Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201615h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
24/06/201615h21Edgar (US Regulatory)(25-NSE)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
10/06/201616h55Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
31/05/201612h00Dow Jones NewsJazz Pharmaceuticals Agrees to Buy Celator for About $1.5 BillionNASDAQ:ANACAnacor Pharmaceuticals, Inc.
31/05/201604h50Dow Jones NewsJazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 BillionNASDAQ:ANACAnacor Pharmaceuticals, Inc.
31/05/201604h49Dow Jones NewsCorrection to Jazz Pharmaceuticals StoryNASDAQ:ANACAnacor Pharmaceuticals, Inc.
26/05/201620h07Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
26/05/201619h49Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
21/05/201604h10Business WireSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc.NASDAQ:ANACAnacor Pharmaceuticals, Inc.
20/05/201622h43Business WireINVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor Pharmaceuticals, Inc. to Pfizer...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
20/05/201620h08Business WireANACOR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Anacor Pharmaceuticals, Inc. (ANAC) Over the P...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
20/05/201614h10PR Newswire (US)Are These Biotech Stocks Prescribed for Investors' Portfolio? - Anacor Pharma, Athersys, Aralez Pharma and Infinity PharmaNASDAQ:ANACAnacor Pharmaceuticals, Inc.
20/05/201604h10PR Newswire (US)SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc. -AN...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
19/05/201622h37Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
19/05/201619h33Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the Sale of Anacor Pharmaceuticals...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
18/05/201622h28Business WireAnacor Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Merger with Pfiz...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
18/05/201616h41PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Anacor Pharmaceuticals, Inc.NASDAQ:ANACAnacor Pharmaceuticals, Inc.
17/05/201623h02Business WireINVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. & Encourages I...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
17/05/201620h44PR Newswire (US)INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Anacor Pharmaceuticals, ...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
17/05/201619h26PR Newswire (US)Block & Leviton LLP Investigates Anacor Pharmaceuticals Inc., Inc. for Possible Breaches of Fiduciary Duty in Connection with...NASDAQ:ANACAnacor Pharmaceuticals, Inc.
17/05/201609h06Dow Jones NewsPfizer Buys Anacor In Turn to Smaller Deals -- WSJNASDAQ:ANACAnacor Pharmaceuticals, Inc.
17/05/201600h17Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ANACAnacor Pharmaceuticals, Inc.
 Showing the most relevant articles for your search:NASDAQ:ANAC

Dernières Valeurs Consultées

NASDAQ
FPAYX
Future Path 529 College ...
NYSE
JBT
John Bean Technologies
TG
CZ45VC
Commerzbank
COIN
GERAGBP
Gera
TG
A2R33N
BANKIA
NASDAQ
CACC
Credit Acceptance
EU
ACANL
Credit Agricole SA 0.203...
NASDAQ
AMBC
Ambac Financial
LSE
TRIO
Trio Finance
TG
75Z
Soho House &
LSE
AAP1
1x Aapl
LSE
LDAG
L&g Div Apac
EU
FR2CIBFS7669
Credit Agricole CIB FCIA...
TG
A18044
United States of America
BIT
P1LT48
BNP Paribas Issuance
ASX
DGL
DGL
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés